Maintenance dose in patients with type 2 diabetes mellitus and chronic kidney disease: After at least 4 weeks on the 0.5 mg dose, increase to 1 mg subcutaneously once a week
Its important to work with your medical provider, who will help customize the safest, most effective dose for you
Dry eye syndrome is caused by decreased tear production caused by age, medical conditions (diabetes, rheumatoid arthritis, thyroid disorders), or medications (antihistamines, decongestants, blood pressure medications)
Tracking the right metrics during your transition from tirzepatide to retatrutide provides objective data about whether the switch is working, whether your dose needs adjustment, and whether you are experiencing the full benefit of triple receptor agonism
This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle